[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[2]Allergy Department;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
[1]Department of Oncology;
Tongji Hospital;
Tongji Medical College;
Huazhong University of Science and Technology;
Wuhan 430030;
China;
Endostar; bevacizumab; malignant pleural effusion; EGFR-/ALK-lung adenocarcinoma; cisplatin; pemetrexed; intra-pleural injection;